Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,749	5,439	6,669	7,738	4,819	3,819
Trading Asset Securities	8,021	6,266	5,161	3,178	3,045	1,675
Cash & Short-Term Investments	11,770	11,705	11,830	10,916	7,863	5,494
Cash Growth	7.73%	-1.06%	8.37%	38.82%	43.13%	30.28%
Accounts Receivable	1,181	2,109	2,257	2,782	2,850	2,183
Other Receivables	20.76	27.81	12.5	14.99	17.2	11.98
Receivables	1,202	2,137	2,270	2,797	2,867	2,195
Inventory	400.31	309.67	569.09	490.08	391.48	375.59
Other Current Assets	65.26	28.68	32.6	32.5	54.23	58.34
Total Current Assets	13,438	14,180	14,702	14,235	11,177	8,123
Property, Plant & Equipment	2,334	2,445	2,706	2,922	2,856	3,034
Long-Term Investments	493.22	473.11	464.71	393.97	332.34	328.44
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	446.95	337.89	308.56	305.01	320.62	280.04
Long-Term Deferred Tax Assets	31.09	49.44	41.83	45.45	62.16	57.32
Long-Term Deferred Charges	8.57	10.01	2.38	11.91	3.87	13.19
Other Long-Term Assets	89.92	37.79	66.44	62.16	62.14	127.96
Total Assets	17,009	17,700	18,459	18,144	14,981	12,131

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,019	1,314	1,730	2,141	1,505	945.77
Accrued Expenses	72.04	305.26	254.87	246.62	350.39	242.7
Short-Term Debt	1,230	717.55	836.39	1,088	400	-
Current Portion of Long-Term Debt	187.7	-	-	-	-	627.55
Current Portion of Leases	-	0.67	1.07	1.06	0.44	1.55
Current Income Taxes Payable	104.39	164.5	99.77	182.62	106.09	43.71
Current Unearned Revenue	25.89	13.62	17.92	17.25	49.14	19.34
Other Current Liabilities	336.55	360.29	598.01	915.86	1,016	919.98
Total Current Liabilities	2,976	2,876	3,538	4,592	3,427	2,801
Long-Term Leases	16.98	0.81	1.04	1.43	0.2	1.02
Long-Term Unearned Revenue	53.71	58.14	65.45	71.43	78.19	84.63
Long-Term Deferred Tax Liabilities	147.42	132.6	127.84	109.28	122.05	112.38
Other Long-Term Liabilities	0.23	0.29	0.53	0.82	1.06	1.35
Total Liabilities	3,194	3,068	3,733	4,775	3,629	3,000

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	452.7	452.51	452.69	452.74	452.74	436.27
Additional Paid-In Capital	4,023	4,016	4,012	3,999	3,984	3,148
Retained Earnings	9,389	10,204	10,345	9,010	6,998	5,431
Treasury Stock	-74.66	-66.74	-108.57	-111.97	-97.18	-
Comprehensive Income & Other	-	-	-	-	-	100.81
Total Common Equity	13,790	14,606	14,702	13,349	11,337	9,117
Minority Interest	24.9	27.11	24.57	19.42	15.14	14.17
Shareholders' Equity	13,815	14,633	14,726	13,369	11,352	9,131
Total Liabilities & Equity	17,009	17,700	18,459	18,144	14,981	12,131

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,435	719.03	838.5	1,090	400.65	630.12
Net Cash (Debt)	10,335	10,986	10,992	9,826	7,463	4,864
Net Cash Growth	0.58%	-0.06%	11.86%	31.67%	53.43%	34.56%
Net Cash Per Share	11.26	11.93	11.98	10.72	8.22	5.40
Filing Date Shares Outstanding	935.82	921.34	911.19	921.81	921.82	888.27
Total Common Shares Outstanding	935.82	921.34	911.19	921.81	921.82	888.27
Working Capital	10,462	11,304	11,164	9,644	7,749	5,322
Book Value Per Share	14.74	15.85	16.13	14.48	12.30	10.26
Tangible Book Value	13,176	14,100	14,226	12,877	10,849	8,670
Tangible Book Value Per Share	14.08	15.30	15.61	13.97	11.77	9.76
Buildings	-	3,008	2,953	2,911	2,455	2,473
Machinery	-	1,768	1,728	1,685	1,644	1,566
Construction In Progress	-	56.32	156.63	186.98	352.15	322.17

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error